Search Within

Rohit Thummalapalli

Formats
  1. Journal Article (14)
  2. Meeting Abstract (11)
Groups
  1. Department of Medicine (25)
  2. GME, Medicine (25)
  3. Graduate Medical Education (25)
  4. Hematology-Oncology Fellows (25)
  5. Solid Tumor Oncology Division (25)
  6. Thoracic Oncology (22)

More Groups

People
  1. Adam Schoenfeld (12)
  2. Arielle Elkrief (9)
  3. Marc Ladanyi (8)
  4. Gregory Riely (7)
  5. Kathryn Arbour (6)
  6. Chaitanya Bandlamudi (4)

More People

Years
  1. 2025 (9)
  2. 2024 (7)
  3. 2023 (9)
Publications
  1. Journal of Clinical Oncology (7)
  2. Journal of Thoracic Oncology (5)
  3. Clinical Cancer Research (3)
  4. Annals of Oncology (2)
  5. JCO Precision Oncology (2)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Elsevier Inc. (5)
  3. American Association for Cancer Research (4)
  4. Oxford University Press (3)
  5. Biomed Central Ltd (1)
  6. Cell Press (1)

More Publishers

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Consolidation EGFR-tyrosine kinase inhibitor (TKI)vs. durvalumab vs. observation in unresectable EGFR-mutant stage III NSCLC
    Meeting Abstract

    Nassar, A. H.; Adib, E.; Kaldas, D.; Feng, J.; AbuAli, T.; Aredo, J.; Fitzgerald, B.; Bar, J.; Thummalapalli, R.; Parikh, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Lorlatinib tolerability and association with clinical outcomes in patients with advanced ALK- or ROS1-rearranged NSCLC: A brief report
    Journal Article

    Thummalapalli, R.; Choudhury, N. J.; Ehrich, F.; Beardslee, T.; Brazel, D.; Zhang, S. S.; Merchant, S.; Chen, M. F.; Heller, G.; Ramalingam, S. S.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Meeting Abstract

    Arbour, K. C.; Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Luo, J.; Alessi, J. V. M.; Pecci, F.; Lamberti, G.; Hong, Lingzhi; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Response to neoadjuvant immune checkpoint inhibitor (ICI)-based therapy in oncogene-driven resectable non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Rosner, S.; Sivapalan, L.; Zahurak, M.; Thummalapalli, R.; Rayes, R.; Connor, S.; Sanber, K.; Reuss, J. E.; Pereira, G.; Smith, K. N.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save